Chronic Myelogenous Leukemia
Showing NaN - NaN of 13
Chronic Myelogenous Leukemia Trial in Worldwide (ABL001 40mg BID, ABL001 80mg QD, ABL001 200mg QD)
Recruiting
- Chronic Myelogenous Leukemia
- ABL001 40mg BID
- +2 more
-
Caba, Buenos Aires, Argentina
- +53 more
Jan 27, 2023
Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)
Active, not recruiting
- Chronic Myelogenous Leukemia
-
Chicago, Illinois
- +87 more
Jan 20, 2023
Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)
Completed
- Chronic Myelogenous Leukemia
-
Fayetteville, Arkansas
- +22 more
Jun 29, 2021
Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial
Completed
- Chronic Myelogenous Leukemia
- +3 more
-
Duarte, California
- +100 more
Jun 8, 2021
Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))
Completed
- Chronic Myelogenous Leukemia
- decitabine (5-aza-2'deoxycytidine)
-
Duarte, California
- +7 more
Jan 13, 2020
Chronic Myelogenous Leukemia Trial in Toronto (imatinib mesylate)
Completed
- Chronic Myelogenous Leukemia
- imatinib mesylate
-
Toronto, CanadaNovartis Investigative Site
Feb 21, 2017
CHRONIC MYELOGENOUS LEUKEMIA Trial in Worldwide (Nilotinib, Imatinib)
Completed
- CHRONIC MYELOGENOUS LEUKEMIA
-
Caba, Buenos Aires, Argentina
- +29 more
Oct 4, 2016
Hematologic Malignancy, Acute Lymphocytic Leukemia, Chronic Lymphocytic Leukemia Trial in Vancouver, Toronto (Ciclopirox
Completed
- Hematologic Malignancy
- +6 more
- Ciclopirox Olamine
-
Vancouver, British Columbia, Canada
- +1 more
Jun 19, 2015
Chronic Myelogenous Leukemia Trial in Worldwide (imatinib mesilate, interferon-alpha (INF-a), cytarabine (ARA-C))
Completed
- Chronic Myelogenous Leukemia
- imatinib mesilate
- +2 more
-
Birmingham, Alabama
- +162 more
Aug 7, 2013
Chronic Myelogenous Leukemia Trial in Canada (nilotinib)
No longer available
- Chronic Myelogenous Leukemia
-
Calgary, Alberta, Canada
- +17 more
Jul 12, 2011
Chronic Myelogenous Leukemia Trial in Worldwide (Dasatinib)
Completed
- Chronic Myelogenous Leukemia
-
Birmingham, Alabama
- +69 more
Apr 13, 2011
Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))
Completed
- Chronic Myelogenous Leukemia
- decitabine (5-aza-2'deoxycytidine)
-
Duarte, California
- +7 more
Oct 12, 2009
Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))
Completed
- Chronic Myelogenous Leukemia
- decitabine (5-aza-2'deoxycytidine)
-
Duarte, California
- +7 more
Dec 12, 2007